Physician profile
Morgan Rowell
NPI 1942853775
$2,480.15
in general payments reported to CMS, 2019-2025
17 companies · $970 in 2025
The $970 reported for 2025 was more than what 86% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $359 · 2022: $539 · 2023: $303 · 2024: $309 · 2025: $970.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,582.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,582.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $797.54 | 2021-2023 | Carto 3 |
| Abiomed | $267.78 | 2025 | |
| Boston Scientific Corporation | $141.57 | 2025 | Watchman Flx |
| Sumitomo Pharma America, INC. | $124.99 | 2023 | Gemtesa |
| Axsome Therapeutics, INC. | $124.36 | 2025 | Auvelity |
| Kyowa Kirin, INC. | $120.56 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $114.14 | 2025 | Austedo Xr |
| Amarin Pharma, INC. | $112.65 | 2025 | Vascepa |
| Abbott Laboratories | $111.37 | 2023 | Freestyle Libre 3 |
| Lucid Diagnostics INC. | $102.14 | 2022 | |
| Acadia Pharmaceuticals INC | $97.44 | 2024 | Daybue |
| W. L. Gore & Associates, INC. | $91.99 | 2024 | Gore Viabahn Endoprosthesis With Heparin |
| Cvrx, INC. | $88.53 | 2025 | Barostim Neo System |
| Pfizer INC. | $81.40 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.37 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $38.55 | 2024 | |
| Corcept Therapeutics | $11.77 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Rowell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.